We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00522600
First Posted: August 30, 2007
Last Update Posted: July 22, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Alcon Research
Information provided by:
Robin, Alan L., M.D.
  Purpose
This study will be used to evaluate how patients put eye drops in their eyes and any problems that may arise from this activity. The information gathered will help identify common problems patients are having with putting in their eye medications. Then doctors can be better informed about the issues and provide better advice to their patients to overcome these problems.

Condition
Glaucoma Dry Eye Syndrome Conjunctivitis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of Eye Drop Administration in Glaucoma Patients

Resource links provided by NLM:


Further study details as provided by Robin, Alan L., M.D.:

Enrollment: 200
Study Start Date: February 2007
Study Completion Date: July 2007
Detailed Description:

Approximately 100 patients will take part in a one time procedure and survey as part of this project. After appropriate consent patients are asked to complete a short 2 page survey about themselves and their eye drops. Then a video recording will be made of the patient instilling eye drops in their habitual manner. The eye drops used will be sterile saline placed in either Travatan-like or Systane bottles to simulate the corresponding prescribed medication. The videos will be graded for instillation technique and combined with scoring of survey answers.

Patients will be asked to instill the drops to their left eye with their dominant hand as we expect this to be most difficult. Patients with severe (>20/200) vision loss will instill drops into their better seeing eye.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
173 subjects enrolled and 222 video recordings were made. Ages ranged from 21-94 years old (mean:67 yrs) and subjects were 55% female and 70% caucasian.
Criteria

Inclusion Criteria:

  • Currently using topical glaucoma medications
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00522600


Locations
United States, Maryland
ALan L Robin MD PA
Baltimore, Maryland, United States, 21209
Sponsors and Collaborators
Robin, Alan L., M.D.
Alcon Research
Investigators
Principal Investigator: Jennifer L Stone, OD Alan L Robin MD PA
Study Director: Alan L Robin, MD Alan L Robin MD PA
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jennifer L. Stone, OD, Glaucoma Specialists
ClinicalTrials.gov Identifier: NCT00522600     History of Changes
Other Study ID Numbers: SI0717
First Submitted: August 29, 2007
First Posted: August 30, 2007
Last Update Posted: July 22, 2009
Last Verified: July 2009

Keywords provided by Robin, Alan L., M.D.:
eyedrops
compliance
glaucoma medications
adherence

Additional relevant MeSH terms:
Glaucoma
Conjunctivitis
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Ocular Hypertension
Eye Diseases
Conjunctival Diseases
Lacrimal Apparatus Diseases
Keratoconjunctivitis
Keratitis
Corneal Diseases
Ophthalmic Solutions
Pharmaceutical Solutions